Delivery Order SPE2DB20D2104-SPE2DB20FQ82S
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Prime Vendor Pharmaceutical contract with the Defense Logistics Agency (DLA) valued at $7,181.84. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,155.88 and an ultimate completion date of December 8, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for a pharmaceutical prime vendor supply contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,202.76 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,520.18, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical division and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The IDC, which runs through December 31, 2025, serves as the primary vehicle for Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of parent company Cencora, Inc., was issued by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award, valued at up to $3,606.40, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a ceiling value of $4,960.22. The contract is for the delivery of a wide range of pharmaceutical products, medical supplies, and other healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a pharmaceutical prime vendor agreement with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,487.43 and an ultimate completion date of November 17, 2020. It is a firm-fixed price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of a broad range of pharmaceutical products and medical supplies to support the U.S. Department of Defense and other federal healthcare programs. The contract, valued at $3,987.50, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB20FQ82SDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is for a Prime Vendor Pharmaceutical contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,423.87 and is for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide essential medications, vaccines, medical devices, and other critical care materials to the Department of Defense globally. This contract covers a comprehensive array of pharmaceutical and medical commodities across multiple therapeutic areas. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential healthcare resources for military personnel, veterans, and other federal beneficiaries. The contract awards reviewed do not have any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/16/20 |